Subscribe
Machinery & Materials
Markets
Logistics & Cold Chain
Issues
Events
Newsletters
Teva
More from Teva
Pharmaceutical
U.S. Faces Shortage of Childhood Cancer Drug
Teva Pharmaceuticals stopped production of vincristine, which is used to treat multiple forms of childhood cancer.
Pharmaceutical
FDA Approves Biosimilar, But it Comes with a Severe Label Warning
Truxima is the first FDA-approved biosimilar to Roche’s blockbuster drug for non-Hodgkin’s lymphoma.
Pharmaceutical
Teva’s Generic EpiPen First to Gain FDA Approval
Approval of the first generic competitor to Mylan’s EpiPen will spark downward pressure on the high-scrutinized price of the original.
Pharmaceutical
Top 10 Patent Cliffs of 2017
Patent expiration is clearing a path for generics to take over; here’s a look at the top 10 patents expiring this year.
Home
Teva Signs Deal on Metered-Dose Marijuana Inhaler
Generics manufacturer holds exclusive distribution rights to discreet dosing system.
Package design
Teva Signs Deal on Metered-Dose Marijuana Inhaler
Generics manufacturer holds exclusive distribution rights to discreet dosing system.
Home
Teva Expects to Pay $500M+ for Bribery Allegations
Teva in “advanced discussions” to settle DOJ and SEC accusations of bribery in foreign countries.
Regulatory
Teva Expects to Pay $500M+ for Bribery Allegations
Teva in “advanced discussions” to settle DOJ and SEC accusations of bribery in foreign countries.
Pharmaceutical
FDA Pauses Regeneron/Teva Painkiller Study
Opioid-alternative fasinumab gets halted during mid-stage trial due safety concerns.
